Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: August 18, 2018

DrugPatentWatch Database Preview

Par Form Company Profile

« Back to Dashboard

What is the competitive landscape for PAR FORM, and what generic and branded alternatives to PAR FORM drugs are available?

PAR FORM has five approved drugs.

There is one tentative approval on PAR FORM drugs.

Summary for Par Form

US Patents:	0
Tradenames:	5
Ingredients:	5
NDAs:	5
Patent Litigation for Par Form:	See patent lawsuits for Par Form

Drugs and US Patents for Par Form

+ Get email alerts for changes to this table

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Par Form	MAFENIDE ACETATE	mafenide acetate	FOR SOLUTION;TOPICAL	201511-001	Feb 12, 2013	AT	RX	No	No		➤ Sign Up				➤ Sign Up
Par Form	FLUOXETINE HYDROCHLORIDE	fluoxetine hydrochloride	TABLET;ORAL	203836-002	Aug 19, 2016	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Par Form	LABETALOL HYDROCHLORIDE	labetalol hydrochloride	TABLET;ORAL	200908-001	Jul 10, 2012	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Par Form	ZOLPIDEM TARTRATE	zolpidem tartrate	TABLET;SUBLINGUAL	201509-002	Aug 1, 2016	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Par Form	LABETALOL HYDROCHLORIDE	labetalol hydrochloride	TABLET;ORAL	200908-003	Jul 10, 2012	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Par Form	LABETALOL HYDROCHLORIDE	labetalol hydrochloride	TABLET;ORAL	200908-002	Jul 10, 2012	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim

Daiichi Sankyo

Chinese Patent Office

Colorcon

Citi

QuintilesIMS

McKinsey

Fuji

Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.